-transparent.png){kind=logo}
Reserpine was administered intraperitoneally 3 times weekly to inbred female Syrian BIO hamsters of the 15.16 strain previously shown to be susceptible to methylcholanthrene (MC) induction of mammary cancer. Other groups of hamsters received non-carcinogenic doses of MC along with the reserpine administrations, and an additional group received a carcinogenic dose of MC alone. This last group demonstrated that BIO 15.6 females were indeed susceptible to MC mammary cancer induction, since 4 mg of MC administered by stomach tube (a total dose of 200 mg) caused mammary cancer in 52% of the animals. Mammary cancer was not observed in any of the animals given reserpine or reserpine in combination with the non-carcinogenic dose of MC.
F Homburger, and
C G van Dongen, and
R A Adams, and
E A Soto, and
K J Pai
May 1943,
Glasgow medical journal,
F Homburger, and
C G van Dongen, and
R A Adams, and
E A Soto, and
K J Pai
July 1960,
Western medicine; the medical journal of the west,
F Homburger, and
C G van Dongen, and
R A Adams, and
E A Soto, and
K J Pai
January 1965,
The British journal of dermatology,
F Homburger, and
C G van Dongen, and
R A Adams, and
E A Soto, and
K J Pai
February 1959,
Medical services journal, Canada,
F Homburger, and
C G van Dongen, and
R A Adams, and
E A Soto, and
K J Pai
October 1964,
Journal of neurosurgery,
F Homburger, and
C G van Dongen, and
R A Adams, and
E A Soto, and
K J Pai
November 1958,
Stanford medical bulletin,
F Homburger, and
C G van Dongen, and
R A Adams, and
E A Soto, and
K J Pai
October 1942,
Annals of surgery,
F Homburger, and
C G van Dongen, and
R A Adams, and
E A Soto, and
K J Pai
February 1951,
The Journal of comparative neurology,
F Homburger, and
C G van Dongen, and
R A Adams, and
E A Soto, and
K J Pai
March 2002,
Obstetrics and gynecology clinics of North America,
F Homburger, and
C G van Dongen, and
R A Adams, and
E A Soto, and
K J Pai
October 1945,
The Journal of pathology and bacteriology,
